American Diabetes Association

TABLE 1

Characteristics of the study cohort examined by a hyperglycemic clamp

	n	BMI (kg/m²)	Fasting glucose (mmol/l)	HbA_1c (%)	First-phase insulin (pmol/l)^*	Second-phase insulin (pmol/l)^†
Noncarriers	90	28.4	6.56	5.7	694	312
A3243G carriers	2	24.7	6.35	5.9	390	141

	n	BMI (kg/m²)	Fasting glucose (mmol/l)	HbA_1c (%)	First-phase insulin (pmol/l)^*	Second-phase insulin (pmol/l)^†
Noncarriers	90	28.4	6.56	5.7	694	312
A3243G carriers	2	24.7	6.35	5.9	390	141

First-phase integrated insulin concentrations at 2.5, 5, 7, and 10 min after application of 10 mmol/l hyperglycemia.

†

Second-phase average insulin concentration in the 120- to 180-min range, minus basal.